Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

@article{Mcdougle2008AtypicalAI,
  title={Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.},
  author={Christopher J. Mcdougle and Kimberly Ann Stigler and Craig Erickson and David J. Posey},
  journal={The Journal of clinical psychiatry},
  year={2008},
  volume={69 Suppl 4},
  pages={
          15-20
        }
}
Atypical antipsychotics are emerging as the first-line pharmacologic treatment for irritability (i.e., aggression, self-injurious behavior, and severe tantrums) in children and adolescents with autistic and other pervasive developmental disorders. Results from placebo-controlled and open-label studies of clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole in this subject population are reviewed. Additional placebo-controlled trials and studies of longer-term safety and… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 44 CITATIONS

Similar Papers

Loading similar papers…